Shreya Sapra

Title: Shreya Sapra: Innovator in the Field of Pharmaceutical Sciences

Introduction

Shreya Sapra, an accomplished inventor based in Greater Noida, India, is making significant strides in the pharmaceutical field. With expertise in the development of therapeutic compounds, she is recognized for her innovative contributions, especially in the area of enzyme inhibitors.

Latest Patents

Shreya holds a notable patent entitled "Ectonucleotide pyrophosphatase-phosphodiesterase-1 (ENPP1) inhibitors and uses thereof." This invention reveals compounds that are beneficial for treating conditions associated with the dysfunction of the ENPP1 enzyme. The patent details a specific compound that exhibits inhibitory activity against ENPP1, along with methods for treating conditions linked to the over-expression of the ENPP1 gene. Furthermore, it includes pharmaceutical compositions and kits designed for practical applications in medicine.

Career Highlights

Currently, Shreya is associated with 1cBio, Inc., where she continues to delve into research and development of medical therapies. Her work not only emphasizes innovation but also the practical application of her findings in the pharmaceutical industry, enhancing the potential for improved healthcare solutions.

Collaborations

In her endeavors, Shreya has collaborated with esteemed colleagues like Brahmam Pujala and Amantullah Ansari. This collaborative approach fosters a dynamic environment where innovative ideas can thrive and lead to groundbreaking advancements in their respective fields.

Conclusion

Shreya Sapra's contributions to the world of pharmaceuticals exemplify the impact of innovative thinking on healthcare. With her patent showcasing significant potential in enzyme inhibition therapy, she stands as a dedicated inventor committed to improving global health outcomes through her research and inventions.